medac GmbH

Fehlandtstrasse 3, 20354 Hamburg, Germany
Telephone: +44 (0)1786 458086
Fax: +44 (0)1786 458032
Medical Information e-mail: info@medac-uk.co.uk

Summary of Product Characteristics last updated on the eMC: 05/12/2011
SPC Eposin concentrate for solution for infusion 20mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
Date of revision of text on the SPC:   03-May-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

'Liver impairment' changed to 'severe hepatic impairment'
Updated on 13/02/2007 and displayed until 05/12/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/02/2007 and displayed until 13/02/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/09/2004 and displayed until 09/02/2007
Reasons for adding or updating:
  • Change in co-marketing arrangement
Updated on 19/09/2003 and displayed until 09/09/2004
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   etoposide